Christina K. Augustine
Department of Surgery
Duke University Medical Center
Durham
North Carolina
USA
Name/email consistency: high
- Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. Augustine, C.K., Toshimitsu, H., Jung, S.H., Zipfel, P.A., Yoo, J.S., Yoshimoto, Y., Selim, M.A., Burchette, J., Beasley, G.M., McMahon, N., Padussis, J., Pruitt, S.K., Ali-Osman, F., Tyler, D.S. Mol. Cancer Ther. (2010)
- Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma. Augustine, C.K., Jung, S.H., Sohn, I., Yoo, J.S., Yoshimoto, Y., Olson, J.A., Friedman, H.S., Ali-Osman, F., Tyler, D.S. Mol. Cancer Ther. (2010)
- Genomic and molecular profiling predicts response to temozolomide in melanoma. Augustine, C.K., Yoo, J.S., Potti, A., Yoshimoto, Y., Zipfel, P.A., Friedman, H.S., Nevins, J.R., Ali-Osman, F., Tyler, D.S. Clin. Cancer Res. (2009)
- Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Augustine, C.K., Yoshimoto, Y., Gupta, M., Zipfel, P.A., Selim, M.A., Febbo, P., Pendergast, A.M., Peters, W.P., Tyler, D.S. Cancer Res. (2008)